Send to

Choose Destination
J Fr Ophtalmol. 2019 Dec;42(10):1094-1099. doi: 10.1016/j.jfo.2019.03.037. Epub 2019 Nov 11.

Basal cell carcinomas of the eyelid: Results of an initial surgical management.

Author information

Ophthalmology department, Institut Curie, 35, boulevard de Port-Royal, 75013 Paris, France. Electronic address:
Anatomy and cytopathology department, institut Curie, Paris, France.
ICPO Institut Curie Protontherapy center Orsay, Orsay, France.
Ophthalmology department, Institut Curie, 35, boulevard de Port-Royal, 75013 Paris, France.
Ophthalmology department, Institut Curie, 35, boulevard de Port-Royal, 75013 Paris, France; Université Paris Descartes, Paris, France.



Our objective was to assess the results of surgical management of palpebral basal cell carcinomas (BCC) followed by a second line treatment discussed during a Multidisciplinary Team Meeting (MTM).


This retrospective single-centred study includes all surgically-treated basal cell carcinomas of the eyelids between January 2005 and January 2015. After initial surgery, the cases were systematically discussed during a multidisciplinary team meeting in order to assess the need for additional treatment. Data relative to the patient, tumor and management were pulled from the medical record.


A total of 171 patients were included, with a mean age of 74 years. Among the patients, 151 underwent pentagonal resection of the tumor, and 20 patients had a superficial excision. After surgical management, 120 patients (70.2%) were considered to have sufficient free margins. The other 51 patients (29.8%) had insufficient margins due to remaining tumor cells (38 patients) or free margins less than 1mm. Among these 51 patients with insufficient margins, 19 received a second surgical treatment, 17 patients received adjuvant radiotherapy, and 15 were followed closely with an intensive biannual follow-up program. No patients were lost to follow-up. With a mean follow-up of 42 months (min. 6 months-max. 128 months), 7 out of 171 patients (4.1%) developed a local recurrence. The mean time between surgical management and recurrence was 24 months. The recurrence rate was higher for the group of patients with a recurrent tumor (11.6%) than for the group of patients referred for initial management (2.8%). Incomplete resection was also associated with a higher recurrence rate (3 recurrences out of 51 patients).


The management of basal cell carcinomas of the eyelid is first and foremost surgical with the goal of complete resection confirmed by histopathological analysis. The histological analyses (Mohs micrographic surgery, frozen section technic, paraffin fixation) and recommended sizes of the margins can vary in the literature, with recurrence rates from 1.8% to 9.5%.


In our experience, multidisciplinary management of BCC of the eyelid, including initial macroscopic surgery, histopathological analysis stating the histological type and size of the margins, along with additional treatment discussed in a MTM, allows for a recurrence rate of 4.1%.


Basal cell carcinoma; Carcinome basocellulaire; Eyelid; Fixation paraffine; Histologie; Histology; Multidisciplinary team conference; Oncologie; Oncology; Paraffin fixation; Paupière; Réunion de concertation pluridisciplinaire; Surgical treatment; Traitement chirurgical


Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center